The Complementary Nature of Patient-Reported Outcomes (PROs) and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591)
      QxMD      Google Scholar   
Citation:
J Pain Symptom Manage vol 50 (4) 470-479.e9
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
5
Parents:
2288  
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
   
Pharmas:
 
Grants:
UG1 CA189867, UG1 CA189974, U10 CA21661, U10 CA37422, UG1 CA189823, P30 CA015083, U10 CA037422, U10 CA021661, U10 CA180822  
Corr. Author:
Pam Atheron 
Authors:
                   
Networks:
OH099   
Study
NCCTG-N0591
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords:
Patient reported-outcomes, adverse events, clinical trials